Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement
The complex, costly, and continuously evolving arena of biopharmaceutical product development demands a constant eye on commercialization potential. Continue Reading
drug development
Payer Contact in a “Contactless” World: Achieving Early Engagement
In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform. Continue Reading
Tackling Rare Diseases with an Arsenal of Real-World Data
Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and other high-value subphenotypes. Continue Reading
